7498 Results (Page 37 of 300)
Pharmaceuticals Markets Research Reports
Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
Brazil's Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is expected to grow from $93 Mn in 2022 to $216 Mn in 2030 with a CAGR of 11.20% for the year 2022-30. The expansion of the PNH therapeutics market in Brazil is anticipated to be fueled by the creation of new technologies and treatment options for PNH. For instance, the recent approval of eculizumab (a monoclonal antibody that targets the complement system for the treatment of PNH) has dramatically improved patient outcomes and is probably going to lead to a rise in the demand for PNH medicines in Brazil. The market is segmented by therapy, diagnostic test, and distribution channel. Some key players in this market include Aché Laboratórios, Eurofarma, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring, and Bioverativ.
Argentina Depression Therapeutics Market Analysis
This report presents a strategic analysis of the Argentina Depression Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Depression Therapeutics Market, offering unmatched value, accuracy and expert insights.
India Oncology Drugs Market Analysis
By 2030, it is anticipated that the India oncology drugs market will reach a value of $10.6 Bn from $3.6 Bn in 2022 and is expected to grow at a CAGR of 14.6% during 2022-30. The companies operating in the oncology drug in India market are Roche Diagnostics, Novartis Oncology and Celgene Corporation. This market is segmented on the basis of therapy modality and types of cancer. Factors such as increased awareness about cancer and its treatments, rising disposable incomes, and improved access to healthcare are some of the major drivers of growth in the Indian oncology drug market.
US Pharmaceutical Market Analysis
The US Pharmaceutical Market is projected to grow from $567 Bn in 2022 to $903 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US pharmaceutical market is characterized by a high degree of competition and consolidation, with a few large companies dominating the industry. Some of the top pharmaceutical companies in the US include Pfizer, Johnson & Johnson, Merck & Co., and AbbVie.
Canada Pharmaceutical Market Analysis
Canada's pharmaceutical market size is about $83.08 Bn in 2022 and is expected to witness significant growth of about $141.69 Bn in 2030 with a CAGR of 6.9% as there are a large number of overseas pharmaceutical companies having a presence in Canada. The incidences of chronic diseases among the Canadian population and comorbidities associated with the diseases are likely to positively impact the growth of the pharmaceutical market over the forecast period. The market is segmented by formulation type, route of administration type and prescription type, etc. Some of the leading players in the market are Pfizer, Novartis AG, and Roche.
France Retail Pharmacy Market Analysis
France's Retail Pharmacy Market is projected to grow from $28.56 Bn in 2022 to $45.18 Bn by 2030, registering a CAGR of 5.9% during the forecast period of 2022-2030. The government plays a significant role in the market through its reimbursement policies and regulations, which can impact the profitability of pharmacies. The main player in the France retail pharmacy market is Groupe A.S.P, which is a retail pharmacy chain with more than 600 stores across the country.
South Korea Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the South Korean infectious disease therapeutics market will reach a value of $2.66 Bn from $1.75 Bn in 2022, growing at a CAGR of 5.4% during 2022-2030. Infectious Disease Therapeutics in South Korea is dominated by a few domestic pharmaceutical companies such as Green Cross Corporation, SK Bioscience and GC Pharma. The Infectious Disease Therapeutics market in South Korea is segmented into different therapeutic areas and different diseases type. The major factors affecting the South Korean infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious disease treatment in various areas of South Korea.
Ukraine Pharmaceutical Market Analysis
This report presents a strategic analysis of the Ukraine Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Ukraine Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Tanzania Antiviral Drugs Market Analysis
This report presents a strategic analysis of the Tanzania Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Tanzania Antiviral Drugs Market, offering unmatched value, accuracy and expert insights.
Tanzania Pharmaceutical Market Analysis
This report presents a strategic analysis of the Tanzania Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Tanzania Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Global Dermatological Therapeutics Market Analysis
This report presents a strategic analysis of the Global Dermatological Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Global Dermatological Therapeutics Market, offering unmatched value, accuracy, and expert insights.
India Dialysis Market Analysis
India's dialysis market is projected to grow from $2.113 Bn in 2022 to $4.368 Bn by 2030, registering a CAGR of 9.50% during the forecast period of 2022 to 2030. The incidence of chronic kidney disease in India is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
UAE Retail Pharmacy Market Analysis
The UAE Retail Pharmacy Market is projected to grow from $5.193 Bn in 2022 to $9.541 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-2030. The market is expected to continue growing at a steady pace in the coming years, with an increasing number of retail pharmacy chains and independent pharmacies opening in the country. Lloyds Pharmacy is a leading retail pharmacy chain in the UAE, with over 70 branches across the country.
India Oral Care Market Analysis
India's oral care market was valued at $641 Mn in 2022 and is estimated to expand at a CAGR of 9.2% from 2022 to 2030 and will reach $1295 Mn in 2030. One of the main reasons propelling the growth of this market is Increasing urbanization, and an aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Dabur India, Patanjali Ayurved, Colgate-Palmolive, Himalaya Wellness, Vicco Laboratories, Procter & Gamble, Baidyanath Ayurveda, and Unilever.
Middle East Breast Cancer Therapeutics Market Analysis
The Middle East breast cancer therapeutics market is expected to grow from $0.72 Bn in 2022 to $2.06 Bn in 2030 with a CAGR of 13.9% for the forecasted year 2022-2030. The main factors contributing to this market growth are public awareness about the treatment options and increased funding for clinical trials for breast cancer medications in the Middle East. The market is segmented by therapy, by cancer type, and by distribution channel. The main competitors in the Middle East breast cancer therapeutics market are Novartis, Mylan, and Eli Lilly.
Latin America Breast Cancer Therapeutics Market Analysis
The Latin America breast cancer therapeutics market is expected to grow from $0.81 Bn in 2022 to $2.32 Bn in 2030 with a CAGR of 13.9% for the forecasted year 2022-2030. The increasing prevalence of breast cancer and rising public awareness about the available therapies and advancements are the major market drivers in the Latin America breast cancer therapeutics market. The market is segmented by therapy, by cancer type, and by distribution channel. Medley Genomics, Eurofarma Laboratrios, and Ach Laboratrios Farmacuticos are some of the key players in the Latin America breast cancer therapeutics market.
Latin America Acne Therapeutics Market Analysis
This report presents a strategic analysis of the Latin America Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Latin America Acne Therapeutics Market, offering unmatched value, accuracy and expert insights.
Latin America Alzheimer’s Disease Drugs Market Analysis
Latin America Alzheimer’s disease drugs market was valued at $694 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.42% from 2022 to 2030 and will reach $1426 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Eisai Co, Novartis International AG, Pfizer, Merck & Co, Johnson & Johnson, Eli Lilly, and Company and Biogen among others.
Spain Cardiac Arrhythmia Therapeutics Market Analysis
Spain Cardiac Arrhythmia Therapeutics Market valued at $139 Mn in 2022, projected to reach $202 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include a surge in the prevalence of cardiac diseases, government initiatives, and emerging treatment options. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Actelion, AstraZeneca, Boston Scientific, and Biosense Webster among others.
Vietnam Cardiac Arrhythmia Therapeutics Market Analysis
Vietnam Cardiac Arrhythmia Therapeutics Market valued at $36 Mn in 2022, projected to reach $58 Mn by 2030 with a 6.03% CAGR. The key drivers of this industry include the rising incidence of cardiac arrhythmias, government initiatives, and increasing healthcare expenditure. The industry is primarily dominated by players such as Abbott, Mylan, Sun Pharma, Novartis, Bayer, Fresenius, Johnson & Johnson, and Medtronic among others.
Africa Breast Cancer Therapeutics Market Analysis
The Africa breast cancer therapeutics market is projected to grow from $273 Mn in 2022 to $801 Mn by 2030, registering a CAGR of 14.4% during the forecast period of 2022-2030. The main factors responsible for this market growth are the increasing prevalence of breast cancer cases and the rising demand for the treatment of breast cancer treatment in Africa. The market is segmented by therapy, by cancer type, and by distribution channel. Pfizer, Novartis, and Merck are some of the key players in the Africa breast cancer therapeutics market.
South Africa Cardiac Arrhythmia Therapeutics Market Analysis
South Africa Cardiac Arrhythmia Therapeutics Market valued at $47 Mn in 2022, projected to reach $81 Mn by 2030 with a 7.03% CAGR. The key drivers of this industry include the rising burden of cardiovascular diseases, technological advancements, and supportive government policies. The industry is primarily dominated by players such as Abbott, Pfizer, MediRite, Clicks Group, Ascendis, Dis-Chem, and Medtronic among others.
Saudi Arabia Cardiac Arrhythmia Therapeutics Market Analysis
Saudi Arabia Cardiac Arrhythmia Therapeutics Market valued at $122 Mn in 2022, projected to reach $215 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the increasing prevalence of cardiac diseases, technological advancements, and supportive government initiatives. The industry is primarily dominated by players such as Abbott, Medtronic, Novartis, Pfizer, Johnson & Johnson, and Boston Scientific among others.
Europe Breast Cancer Therapeutics Market Analysis
The Europe breast cancer therapeutics market size was valued at $3.45 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.64% from 2022 to 2030 and will reach $8.34 Bn in 2030. The main factors propelling the Europe breast cancer market are the implementation of breast cancer screening programs and increased research and development initiatives for new drug developments in Europe. The market is segmented by therapy, by cancer type, and by distribution channel. Mylan, AstraZeneca, and Celltrion are some of the main market players in the Europe breast cancer therapeutics market.
Malaysia Cardiac Arrhythmia Therapeutics Market Analysis
Malaysia Cardiac Arrhythmia Therapeutics Market valued at $12 Mn in 2022, projected to reach $18 Mn by 2030 with a 6% CAGR. The key drivers of this industry include the rising prevalence of cardiac arrhythmias, supportive government initiatives, and growing treatment options. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, GE Healthcare, and Siemens among others.
